Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

Clinical trial NCT06215144 · TERMINATED

Trial details

NCT number: NCT06215144
Sponsor: Neurocentria, Inc.
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder (ADHD)

Start date: 2024-01-25
Primary completion: 2025-10-10
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.